Item 5.02. Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

Election of Hany Massarany as Director

On May 20, 2021, the Board of Directors (the "Board") of Accelerate Diagnostics, Inc. (the "Company") elected Hany Massarany as a member of the Board, effective immediately. Mr. Massarany has been appointed to the Nominating and Governance Committee and the Compensation Committee of the Board.

There is no arrangement or understanding between Mr. Massarany and any other person pursuant to which he was selected as a director, and Mr. Massarany does not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K of the Securities Exchange Act of 1934, as amended.

Mr. Massarany will receive the same compensation as the Company's other non-employee directors as generally described under "Executive Compensation-Director Compensation" in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 5, 2021.





Equity Award Grants

On May 20, 2021, the Compensation Committee of the Board granted the following restricted stock units and performance stock units to Jack Phillips, the Company' President and Chief Executive Officer, under the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan.





                                               Restricted Stock          Performance Stock
                   Name                            Units (1)                 Units (2)
Jack Phillips, President and Chief
Executive Officer                                          206,597                   103,299

(1) The restricted stock units vest monthly in 12 equal amounts starting January 13, 2023. Upon vesting, Mr. Phillips will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

(2) The performance stock units will vest in whole upon the Company's achievement of certain annual revenue and operational milestone targets no later than the end of 2023. If such targets are not achieved by the end of 2023, the performance stock units will forfeit. Each vested performance stock unit will be settled in one share of the Company's common stock.

© Edgar Online, source Glimpses